Diabetic Foot
Conditions
Interventions
Intervention type:
Name of intervention:
Dose form / Japanese Medical Device Nomenclature:
Route of administration / Site of application:
Dose per administration:
Dosing frequency / Frequency of use:
Sponsors
National Hospital Organization
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -Patients with type I or II Diabetes -Patients has an ulcer, gangrene and/or charcot -Patients who signed written consent
Exclusion criteria
Exclusion criteria: -Patients with vital prognosis less than a year -Patients whom his/her primary physician determined that he/she is inappropriate as a candidate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of primary healing and amputation | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospitalization, Severity of diabetic foot, resolution of infection, pathogens, antibiotic use (duration and type), vascular intervention (Endovascular or bypass), off-loading, QOL, the rate of recurrence, employment status (the rate of unemployment), the mode of nursing, and cardiovascular events. | — |
Countries
Germany, Japan
Contacts
Public ContactShigeo Kono, MD, PhD
National Hospital Organization Kyoto Medical Center
Outcome results
None listed